Imagine you are developing antibodies—drugs precisely aimed at a target, for example a viral protein or onco-marker. You test a series of antibodies and find that some work, while others do not.

Artificial intelligence is everywhere, from smart assistants to medical research. Yet questions remain about reliability, ...